[go: up one dir, main page]

AR004502A1 - Una asociacion trisecuencial hormonal, estroprogestativa, su utilizacion y un procedimiento para su preparacion - Google Patents

Una asociacion trisecuencial hormonal, estroprogestativa, su utilizacion y un procedimiento para su preparacion

Info

Publication number
AR004502A1
AR004502A1 ARP960103818A AR10381896A AR004502A1 AR 004502 A1 AR004502 A1 AR 004502A1 AR P960103818 A ARP960103818 A AR P960103818A AR 10381896 A AR10381896 A AR 10381896A AR 004502 A1 AR004502 A1 AR 004502A1
Authority
AR
Argentina
Prior art keywords
hormonal
association
tresecuencial
estimate
procedure
Prior art date
Application number
ARP960103818A
Other languages
English (en)
Original Assignee
Theramex
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9481610&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR004502(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Theramex filed Critical Theramex
Publication of AR004502A1 publication Critical patent/AR004502A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La presente invención se refiere al campo de la química terapéutica. Más específicamente tiene por objeto una asociación hormonal, estroprogestativa,trisecuencial, caracterizada porque está constituída por unidades de dosaje que contienensolament e un estrógeno, unidades de dosaje que contienen unacombinación de un estrógeno y de un progestativo y unidades de dosaje que contienen solamente un excipiente. Este modo de administración trisecuencialestá destinado a compensar lostrastornos funcionales provocados por una hipoestrogenia relacionada con la menopausia o la premenopausia.
ARP960103818A 1995-08-01 1996-07-31 Una asociacion trisecuencial hormonal, estroprogestativa, su utilizacion y un procedimiento para su preparacion AR004502A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9509364A FR2737411B1 (fr) 1995-08-01 1995-08-01 Nouveaux medicaments hormonaux et leur utilisation pour la correction des carences estrogeniques

Publications (1)

Publication Number Publication Date
AR004502A1 true AR004502A1 (es) 1998-12-16

Family

ID=9481610

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP960103818A AR004502A1 (es) 1995-08-01 1996-07-31 Una asociacion trisecuencial hormonal, estroprogestativa, su utilizacion y un procedimiento para su preparacion

Country Status (30)

Country Link
US (1) US5891867A (es)
EP (1) EP0783310B1 (es)
JP (1) JPH10507207A (es)
KR (1) KR100450649B1 (es)
CN (1) CN1138547C (es)
AP (1) AP829A (es)
AR (1) AR004502A1 (es)
AT (1) ATE225659T1 (es)
AU (1) AU722355B2 (es)
BR (1) BR9606549A (es)
CA (1) CA2201368C (es)
CZ (1) CZ289706B6 (es)
DE (1) DE69624214T2 (es)
DK (1) DK0783310T3 (es)
DZ (1) DZ2078A1 (es)
ES (1) ES2184880T3 (es)
FR (1) FR2737411B1 (es)
HU (1) HU229843B1 (es)
IL (1) IL120558A (es)
MA (1) MA23946A1 (es)
MX (1) MX9702381A (es)
MY (1) MY117307A (es)
NO (1) NO312996B1 (es)
OA (1) OA10411A (es)
PT (1) PT783310E (es)
RU (1) RU2188641C2 (es)
TN (1) TNSN96101A1 (es)
TW (1) TW473390B (es)
WO (1) WO1997004784A1 (es)
ZA (1) ZA966545B (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001030355A1 (fr) * 1999-10-25 2001-05-03 Laboratoire Theramex Medicament contraceptif a base d'un progestatif et d'un estrogene et son mode de preparation
FR2754179B1 (fr) * 1996-10-08 1998-12-24 Theramex Nouvelle composition hormononale et son utilisation
US6787531B1 (en) * 1999-08-31 2004-09-07 Schering Ag Pharmaceutical composition for use as a contraceptive
WO2001030356A1 (fr) * 1999-10-25 2001-05-03 Laboratoire Theramex Composition hormonale a base d'un progestatif et d'un estrogene et son utilisation
US20020132801A1 (en) * 2001-01-11 2002-09-19 Schering Aktiengesellschaft Drospirenone for hormone replacement therapy
FR2814074B1 (fr) * 2000-09-15 2003-03-07 Theramex Nouvelles compositions estro-progestatives topiques a effet systemique
US20020151732A1 (en) * 2001-01-05 2002-10-17 Claes Ohlsson Estrogen receptors
US20030004145A1 (en) 2001-05-16 2003-01-02 Leonard Thomas W. Treatment of conditions relating to hormone deficiencies by administration of progestins
IL162182A0 (en) * 2001-12-05 2005-11-20 Barr Lab Inc Kits containing oral contraceptives and methods utilizing the same
US7008979B2 (en) * 2002-04-30 2006-03-07 Hydromer, Inc. Coating composition for multiple hydrophilic applications
AU2004257772B2 (en) * 2003-07-16 2009-12-17 Teva Women's Health, Inc. Methods of hormonal treatment utilizing contraceptive regimens with continuous estrogen administration
US20070111975A1 (en) * 2004-10-07 2007-05-17 Duramed Pharmaceuticals, Inc. Methods of Hormonal Treatment Utilizing Ascending-Dose Extended Cycle Regimens
US8022053B2 (en) * 2004-11-02 2011-09-20 Bayer Schering Pharma Aktiengesellschaft Oral solid dosage forms containing a low dose of estradiol
PE20081895A1 (es) * 2007-03-26 2009-01-26 Theramex Regimen anticonceptivo oral

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4390531A (en) * 1981-08-10 1983-06-28 Syntex Pharmaceuticals International Ltd. Method of contraception using peak progestogen dosage
US4826831A (en) * 1983-08-05 1989-05-02 Pre Jay Holdings Limited Method of hormonal treatment for menopausal or post-menopausal disorders involving continuous administration of progestogens and estrogens
US4870066A (en) * 1986-08-11 1989-09-26 The University Of Kentucky Research Foundation Method and composition for safely delaying parturition and synchronizing farrowing in swine
EP0483077B1 (en) * 1990-09-28 1995-12-06 I.F.L.O. S.a.s. di Giorgio e Aldo Laguzzi A method for carrying out the synthesis of a contraceptive and menstrual cycle controlling drug having oncostatic, antikinetosic, preventive and therapeutic properties for treatment of mammary tumours and melanomas.
FR2695826B1 (fr) * 1992-09-21 1995-01-06 Theramex Nouvelles compositions pharmaceutiques à base de dérivés de nomégestrol et leurs procédés d'obtention.

Also Published As

Publication number Publication date
RU2188641C2 (ru) 2002-09-10
CZ289706B6 (cs) 2002-03-13
HUP9900612A2 (hu) 1999-07-28
CN1138547C (zh) 2004-02-18
DK0783310T3 (da) 2003-02-10
ES2184880T3 (es) 2003-04-16
MY117307A (en) 2004-06-30
EP0783310B1 (fr) 2002-10-09
CZ96797A3 (cs) 1998-08-12
IL120558A0 (en) 1997-07-13
KR100450649B1 (ko) 2004-11-16
JPH10507207A (ja) 1998-07-14
TNSN96101A1 (fr) 2005-03-15
AP829A (en) 2000-05-03
MA23946A1 (fr) 1997-04-01
IL120558A (en) 2002-09-12
HK1005227A1 (en) 1998-12-31
WO1997004784A1 (fr) 1997-02-13
OA10411A (fr) 2001-12-06
DZ2078A1 (fr) 2002-10-22
ATE225659T1 (de) 2002-10-15
PT783310E (pt) 2003-02-28
FR2737411B1 (fr) 1997-10-17
NO971449L (no) 1997-05-30
MX9702381A (es) 1998-02-28
ZA966545B (en) 1997-05-08
DE69624214D1 (de) 2002-11-14
CA2201368C (fr) 2010-12-07
CN1167438A (zh) 1997-12-10
HUP9900612A3 (en) 1999-11-29
EP0783310A1 (fr) 1997-07-16
US5891867A (en) 1999-04-06
FR2737411A1 (fr) 1997-02-07
AP9700979A0 (en) 1997-07-31
BR9606549A (pt) 1998-06-23
KR970706004A (ko) 1997-11-03
DE69624214T2 (de) 2003-07-10
AU6367496A (en) 1997-02-26
NO312996B1 (no) 2002-07-29
NO971449D0 (no) 1997-03-26
AU722355B2 (en) 2000-07-27
HU229843B1 (en) 2014-09-29
TW473390B (en) 2002-01-21
CA2201368A1 (fr) 1997-02-13

Similar Documents

Publication Publication Date Title
AR004502A1 (es) Una asociacion trisecuencial hormonal, estroprogestativa, su utilizacion y un procedimiento para su preparacion
CO5170495A1 (es) Composiciones farmaceuticas para prevencion y tratamiento de enfermedades amiloidogenicas
ES2061252T3 (es) Agente antitusivo y regulador de la mucosa, procedimiento para su preparacion y composiciones farmaceuticas que lo contienen.
BR0215193A (pt) Formulações de azitromicina diretamente compressìveis
UY28931A1 (es) Derivados de pirrolotriazina utiles para tratar trastornos hiper-proliferativos y enfermedades asociadas con angiogenesis
TNSN01130A1 (fr) Formulations a liberation prolongee pour des secretagogues d'hormone de croissance
BR9913288A (pt) Composição antioxidante compreendendo acetil l-carnitina e ácido alfa-lipóico
AR035927A1 (es) Compuesto de lactama (n)-((s)-2-hidroxi-3-metilbutiril)-1-(l-alaninil)-(s)-1-amino-3-metil-4,5,6,7-tetrahidro-2h-3-benzazepin-2-ona , composicion farmaceutica que lo comprende, procedimiento para la inhibicion de la liberacion de peptido b-amiloide y/o su sintesis que lo emplea y su uso para la fabr
HUP0102879A2 (hu) Csontritkulás és klimaxos változások megelőzésére és/vagy kezelésére alkalmas készítmény
NZ503963A (en) 1-substituted-1-aminomethyl-cycloalkane derivatives, or gabapentin analogues, preparation and use in the treatment of neurological disorders
BR9909138A (pt) Combinação para o tratamento de dependência de álcool e drogas contendo um antagonista de opióide e um modulador de complexo receptor de nmda
BR9509019A (pt) Processo para fabricar unidades de dosagem farmacêutica e comprimido isento de solventes orgânicos
BR0210013A (pt) Gel oftálmico de pirenzepina
BRPI0114344B8 (pt) composto retinóide, seu uso, sua composição farmacêutica e seu processo de preparação
BR9908510A (pt) Uso de um composto, composto, processo para a preparação de um composto, composição farmacêutica, e, processo de tratar um paciente que sofre de, ou em risco de, uma doença micobacteriana
ES2124905T3 (es) Esteroides antiglucocorticoides destinados al tratamiento de trastornos de ansiedad.
ES2132556T3 (es) Nuevo derivado de benzo-tiadiazina, su procedimiento de preparacion y las composiciones farmaceuticas que lo contienen.
BR9915215A (pt) Composição farmacêutica para liberação modificada de sensibilizador de insulina
HN1999000067A (es) Preparados efervescentes
DE69928806D1 (de) (-)-pseudoephedrin als sympathomimetisches arzneimittel
BR0014979A (pt) Composição hormonal e sua utilização
BR9915123A (pt) Composição de uma substância farmaceuticamente ativa e dispensador
BR9809673A (pt) Derivados de triptolida úteis no tratamento de doenças autoimunes
BR0012058A (pt) Combinação sinérgica: gabapentina e pregabalina
ATE342059T1 (de) Verwendung zur verabreichung von östrogen

Legal Events

Date Code Title Description
FC Refusal